ITMI20022619A1 - Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata. - Google Patents

Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata.

Info

Publication number
ITMI20022619A1
ITMI20022619A1 ITMI20022619A ITMI20022619A1 IT MI20022619 A1 ITMI20022619 A1 IT MI20022619A1 IT MI20022619 A ITMI20022619 A IT MI20022619A IT MI20022619 A1 ITMI20022619 A1 IT MI20022619A1
Authority
IT
Italy
Prior art keywords
soluble
pharmaceutical preparations
acetylsalicylic acid
veterinary use
use containing
Prior art date
Application number
Other languages
English (en)
Inventor
Luigi Fezzi
Giacomo Grassigli
Original Assignee
Ind Italiana Integratori Trei S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Italiana Integratori Trei S P A filed Critical Ind Italiana Integratori Trei S P A
Priority to ITMI20022619 priority Critical patent/ITMI20022619A1/it
Priority to EP03028009A priority patent/EP1428525A1/en
Priority to PL03364014A priority patent/PL364014A1/xx
Publication of ITMI20022619A1 publication Critical patent/ITMI20022619A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
ITMI20022619 2002-12-11 2002-12-11 Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata. ITMI20022619A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI20022619 ITMI20022619A1 (it) 2002-12-11 2002-12-11 Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata.
EP03028009A EP1428525A1 (en) 2002-12-11 2003-12-05 Pharmaceutical preparations for the veterinary use containing acetylsalicylic acid in the form of buffered soluble powder
PL03364014A PL364014A1 (en) 2002-12-11 2003-12-11 Veterinary compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20022619 ITMI20022619A1 (it) 2002-12-11 2002-12-11 Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata.

Publications (1)

Publication Number Publication Date
ITMI20022619A1 true ITMI20022619A1 (it) 2004-06-12

Family

ID=32321430

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI20022619 ITMI20022619A1 (it) 2002-12-11 2002-12-11 Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata.

Country Status (3)

Country Link
EP (1) EP1428525A1 (it)
IT (1) ITMI20022619A1 (it)
PL (1) PL364014A1 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6451310B2 (ja) * 2014-12-24 2019-01-16 ライオン株式会社 固形医薬組成物及びその製造方法
WO2017001468A1 (en) 2015-07-02 2017-01-05 Asamedic As Two-component composition
WO2018002124A1 (en) 2016-06-28 2018-01-04 Asamedic As Two-component composition
EP3501523A1 (en) 2017-12-22 2019-06-26 Asamedic AS Two-component compositions comprising acetyl salicylic acid and a carbonate salt
EP3501522A1 (en) 2017-12-22 2019-06-26 Asamedic AS Compositions comprising acetylsalicylic acid and a phosphate salt
CN116251065B (zh) * 2023-02-20 2024-04-26 山东齐发药业有限公司 Aptm可溶性粉中间体、可溶性粉以及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8525348D0 (en) * 1985-10-15 1985-11-20 Nicholas Kiwi Pacific Pty Ltd Effervescent tablets
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
FR2708853A1 (fr) * 1993-06-30 1995-02-17 Salsarulo Gilles Composition à base d'acide acétylsalicylique à biodisponibilité améliorée et procédé pour la produire.
US5776431A (en) * 1997-03-26 1998-07-07 Galat; Alexander Water-soluble aspirin composition

Also Published As

Publication number Publication date
PL364014A1 (en) 2004-06-14
EP1428525A1 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
IL207028A0 (en) Pharmaceutical nati-tnf-alpha antibody formulation
NO20035654D0 (no) System for avlevering av törrpulverformuleringer
EE05378B1 (et) LahustuvaÁCTLA4ÁsulandmolekuliÁkasutamineÁravimkoostiseÁvalmistamiseks
IL189375A (en) Derivatives 1-Heterocyclicsulfonyl-3-Aminomethyl-5- (hetero-) aryl-1-h- Pyrol
ITTO20010005A1 (it) Formulazione farmaceutica.
PL374347A1 (en) Solid pharmaceutical formulations comprising telmisartan
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
DK1633388T3 (da) Flydende stabiliserede interferon-beta-formuleringer i coatede farmaceutiske beholdere
NO20053987L (no) Flytende farmasoytiske palonosetronformuleringer
ITTO20020524A0 (it) Formulazione a rapida assimilazione preferibilemnte sotto forma di compressa rivestita per uso medico
NO20020086D0 (no) Smaksmaskerte farmasöytiske flytende formuleringer
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
AU2003291689A8 (en) Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization
DK1183026T3 (da) Forbedrede farmaceutiske formuleringer omfattende ritonavir
WO2005065650A3 (en) Aerosol formulations comprising a carboxylic acid surfactant
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
ITMI20022619A1 (it) Preparazioni farmaceutiche ad uso veterinario contenenti acido acetilsalicilico in forma di polvere solubile tamponata.
ITMI20051273A1 (it) Composizioni in forma di lipogel per uso cosmetico detergente e farmaceutico
EE200200252A (et) Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks
IT1320764B1 (it) Uso di composti (per)fluoropolieterei come additivi in formulazioni.
CL2003002588A1 (es) Uso de una composicion farmaceutica que comprende acido n,n-dimetoximetildifenil barbiturico, acido n-metoximetildifenil barbiturico o acido difenil barbiturico o una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el t
AR025867A1 (es) Formulacion portasdora farmaceutica
ITRM20020119A1 (it) Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
IT1318460B1 (it) Conservanti di formulazioni ad uso topico.
NO20042022L (no) Fast legemiddelformulering som inneholder pipiperazinurea-derivat og fremgangsmate for fremstilling av formuleringen